Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed)

The summary for the Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed): This Notice of Funding Opportunity (NOFO) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to develop resources, new methods, and approaches that can be applied in testing strategies to help understand the role of environmental chemicals in the etiology of the neurodevelopmental disorders. There is a need for novel and innovative approaches including New Approach Methodologies (NAMs) that can provide effective ways to address current challenges and gaps in the assessment of Developmental Neurotoxicity (DNT). These screening systems or technologies, when fully developed and validated with appropriate throughput and controls, are expected to provide cost-effective, quicker and/or comprehensive results to understand the underlying role of environmental chemicals in the DNT.
Federal Grant Title: Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Environment Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-ES-23-008
Type of Funding: Grant
CFDA Numbers: 93.113
CFDA Descriptions: Information not provided
Current Application Deadline: July 7th, 2023
Original Application Deadline: July 7th, 2023
Posted Date: March 21st, 2023
Creation Date: March 21st, 2023
Archive Date: August 12th, 2023
Total Program Funding:
Maximum Federal Grant Award: $295,924
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: March 21st, 2023
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-008.html
Grant Announcement Contact
NIH Grants Information
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
Strategies for Responsibly Reporting Back Environmental Health and Non-Genomic Research Re...
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational E...
Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoc...
NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
Outstanding New Environmental Scientist Award (ONES)
Environmental Health Sciences Core Center Grants
Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorde...
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IM...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2023 FederalGrants.com